2D echocardiography is limited for identifying chemotherapy-related cardiotoxicity. This study compared standard echo, 2D, and 3D speckle tracking echocardiography (STE) for detection of subclinical anthracycline (ANT) cardiotoxicity in breast cancer patients
Aims: The efficacy of anthracyclines is undermined by potential life-threatening cardiotoxicity. Car...
The aim of the present study was to find out whether early cardiac changes in patients receiving che...
Background: Because cancer patients survive longer, the impact of cardiotoxicity associated with the...
2D echocardiography is limited for identifying chemotherapy-related cardiotoxicity. This study compa...
Background: Cardiotoxicity is an important complication of several cancertherapeutic agents such as ...
Aim.The study was to assess the deformation properties of the left ventricle (LV) myocardium in pati...
Abstract Background Cancer therapeutics–related cardiac dysfunction (CTRCD) from different chemother...
Diagnosis and management of Cancer therapeutics-related cardiac dysfunction is of crucial importance...
The aim of this retrospective study was to detect early cardiotoxicity by speckle tracking analysis....
With the improvement in survival rate, cardiotoxicity has emerged as a significant adverse effect of...
Abstract Background Combined anthracycline-trastuzumab chemotherapy has been associated with LV dysf...
To evaluate the role of 2D myocardial strain (rate) imaging in the detection of early subclinical ca...
Objective: Speckle tracking echocardiography (STE) enables global and regional evaluation of the lef...
Aims : To assess the chronic cardiac effects of anthracycline-based chemotherapy regimens on atrial ...
Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas
Aims: The efficacy of anthracyclines is undermined by potential life-threatening cardiotoxicity. Car...
The aim of the present study was to find out whether early cardiac changes in patients receiving che...
Background: Because cancer patients survive longer, the impact of cardiotoxicity associated with the...
2D echocardiography is limited for identifying chemotherapy-related cardiotoxicity. This study compa...
Background: Cardiotoxicity is an important complication of several cancertherapeutic agents such as ...
Aim.The study was to assess the deformation properties of the left ventricle (LV) myocardium in pati...
Abstract Background Cancer therapeutics–related cardiac dysfunction (CTRCD) from different chemother...
Diagnosis and management of Cancer therapeutics-related cardiac dysfunction is of crucial importance...
The aim of this retrospective study was to detect early cardiotoxicity by speckle tracking analysis....
With the improvement in survival rate, cardiotoxicity has emerged as a significant adverse effect of...
Abstract Background Combined anthracycline-trastuzumab chemotherapy has been associated with LV dysf...
To evaluate the role of 2D myocardial strain (rate) imaging in the detection of early subclinical ca...
Objective: Speckle tracking echocardiography (STE) enables global and regional evaluation of the lef...
Aims : To assess the chronic cardiac effects of anthracycline-based chemotherapy regimens on atrial ...
Imaging- and therapeutic targets in neoplastic and musculoskeletal inflammatory diseas
Aims: The efficacy of anthracyclines is undermined by potential life-threatening cardiotoxicity. Car...
The aim of the present study was to find out whether early cardiac changes in patients receiving che...
Background: Because cancer patients survive longer, the impact of cardiotoxicity associated with the...